Systemic lupus erythematosus: pharmacological developments and recommendations for a therapeutic strategy

Author： Pego-Reigosa Jose Maria   Isenberg David A  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.17, Iss.1, 2008-01, pp. : 31-41

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetic and Pharmacological Modulation of Dendritic Cell-T Cell Interactions as a Therapeutic Strategy for Systemic Lupus Erythematosus

By  

Current Gene Therapy, Vol. 11, Iss. 6, 2011-01 ,pp. : 544-553

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of IL-27 in systemic lupus erythematosus

By Pan Hai-Feng   Tao Jin-Hui   Ye Dong-Qing  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 5, 2010-05 ,pp. : 479-484

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Targets of Misguided T Cells in Systemic Lupus Erythematosus

By  

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 3, 2005-06 ,pp. : 295-298

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropsychiatric Involvement in Systemic Lupus Erythematosus:Current Therapeutic Approach

By  

Current Pharmaceutical Design, Vol. 14, Iss. 13, 2008-05 ,pp. : 1261-1269

Bentham Science Publishers

Access to resources Recommend Favorite

Novel and Emerging Drugs for Systemic Lupus Erythematosus: Mechanism of Action and Therapeutic Activity

By  

Current Medicinal Chemistry, Vol. 19, Iss. 3, 2012-01 ,pp. : 438-453

Bentham Science Publishers

Access to resources Recommend Favorite